Oral Ferric Citrate Hydrate Associated With Less Oxidative Stress Than Intravenous Saccharated Ferric Oxide
Masaaki Nakayama1,2,3, Yoshihiro Tani3,4, Wan-Jun Zhu1,2, Kimio Watanabe5, Keitaro Yokoyama6, Masafumi Fukagawa7, Takashi Akiba8, Myles Wolf9, Hideki Hirakata10
1Research Division of Chronic Kidney Disease and Dialysis Treatment, Tohoku University, Tohoku University Hospital, Sendai, Japan
2Core Center of Advanced Integrated Renal Science, Tohoku University, Sendai, Japan
3Department of Nephrology, Hypertension, Fukushima Medical University School of Medicine, Fukushima, Japan
4Jikyukai Tani Hospital, Dialysis Unit, Motomiya, Japan
5Tohoku University Hospital, Division of Blood Purification, Sendai, Japan
6Division of Nephrology and Hypertension, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan
7Division of Nephrology, Endocrinology and Metabolism, Tokai University School of Medicine, Isehara, Japan
8Sekikawa Hospital, Tokyo, Japan
9Duke University School of Medicine, Division of Nephrology, Department of Medicine and Duke Clinical Research Institute, Durham, North Carolina, USA
10Fukuoka Renal Clinic, Fukuoka, Japan
Tài liệu tham khảo
Thông tin
Thông tin xuất bản
Kidney International Reports
Tập 3
364-373
Thông tin tác giả